Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

August 23, 2022 updated by: Asst. Prof. Zeynep Gunes Ozunal, M.D., Maltepe University
Study is an observational study among hypertensive patients

Study Overview

Status

Completed

Conditions

Detailed Description

Objective: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) control among hypertensive patients that have uncontrolled and controlled BP.

Study Type

Observational

Enrollment (Actual)

176

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 74 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

hypertensive patients

Description

Patient inclusion criteria were as follows:

  • aged between 38 and 74 years,
  • hypertension diagnosis history of at least 6 months
  • use of at least one antihypertensive medication.

Exclusion Criteria:

-not willing to join the clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
controlled hypertension
Controlled hypertension was defined as systolic blood pressure (SBP) ≤139 mmHg and/or diastolic blood pressure (DBP)≤89 mmHg for non-diabetic patients, and as SBP ≤139 mmHg and/or DBP ≤84 mmHg for diabetic patients, based on the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) guidelines. observational study
uncontrolled hypertensive patients.
Individuals who had blood pressure levels above these values were defined as uncontrolled hypertensive patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
health related quality of life.
Time Frame: at the time of the beginning of the study
EQ-5D-3L turkish validation test
at the time of the beginning of the study
Age
Time Frame: at the time of the beginning of the study
years
at the time of the beginning of the study
Gender
Time Frame: at the time of the beginning of the study
Female/Male
at the time of the beginning of the study
BMI
Time Frame: at the time of the beginning of the study
(kg/m2)
at the time of the beginning of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complementary and alternative medicine use
Time Frame: at the time of the beginning of the study
subjective reports from patients (yes/no)
at the time of the beginning of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Maltepe University

Collaborators

Istanbul University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 16, 2014

Primary Completion (Actual)

November 30, 2014

Study Completion (Actual)

November 30, 2014

Study Registration Dates

First Submitted

August 24, 2017

First Submitted That Met QC Criteria

August 23, 2022

First Posted (Actual)

August 24, 2022

Study Record Updates

Last Update Posted (Actual)

August 24, 2022

Last Update Submitted That Met QC Criteria

August 23, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 000001 (Kaiser Permanente Southern California IRB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension,Essential

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe